| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 77, 1318-1322, Copyright © 1993 by Endocrine Society
ARTICLES |
AM Parfitt, GD Braunstein and A Katz
Henry Ford Hospital, Bone and Mineral Research Laboratory, Detroit, Michigan 48202.
In sporadic parathyroid adenomas, the birth rate of new cells, based on the proportion of S-phase cells at the time of surgical excision, is much too low to account for growth of the tumor from a single cell, as is required by monoclonal origin, even if the mutation occurred in utero, indicating that the rate of cell proliferation has slowed down during the course of the disease. In radiation-associated hyperparathyroidism, the age at irradiation provides a more accurate upper limit to the age of the tumor. The purpose of this study was to relate this age to the prevalence of mitosis as an alternative index of current cell proliferation. In 56 such patients, the geometric mean for the minimum cell birth rate needed for growth from a single cell to the observed size in the time available was 54.4%. In 44 patients, including 31 of the previous 56 and an additional 13, sampling an average of 220,000 cell profiles, 15 mitoses were found, an overall prevalence of 0.15/10(5), which corresponds to a cell birth rate of 2.7%/yr, assuming the duration of mitosis to be 0.5 h. If cases with no mitosis were assigned a value of half the detection limit, the geometric mean mitotic index was 0.360/10(5), and the corresponding cell birth rate was 6.4%/yr. This is more than 8 times smaller than the minimum birth rate required and 20 times smaller than the cell birth rate in meningiomas, suggesting that such extreme reduction of cell birth rate is a unique feature of parathyroid adenomas, rather than a general feature of all benign tumors. The data support the set-point hypothesis, which reconciles the earlier concept of focal hyperplasia with monoclonal origin and provides an alternative nonneoplastic mechanism of etiology for the usual nonprogressive form of the disease.
This article has been cited by other articles:
![]() |
L. Elangovan, A. J. Felsenfeld, and C. R. Kleeman Spontaneous resolution and recurrence of hypercalcemia in primary hyperparathyroidism—anecdotal observations with potential implications for parathyroid pathophysiology in renal disease Nephrol. Dial. Transplant., October 1, 1999; 14(10): 2323 - 2327. [Full Text] [PDF] |
||||
![]() |
G. R. Mundy and T. A. Guise Hormonal Control of Calcium Homeostasis Clin. Chem., August 1, 1999; 45(8): 1347 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Parfitt, Q. Wang, and S. Palnitkar Rates of Cell Proliferation in Adenomatous, Suppressed, and Normal Parathyroid Tissue: Implications for Pathogenesis J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 863 - 869. [Abstract] [Full Text] |
||||
![]() |
S. Yamaguchi, S. Yachiku, and M. Morikawa Analysis of Proliferative Activity of the Parathyroid Glands Using Proliferating Cell Nuclear Antigen in Patients with Hyperparathyroidism J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2681 - 2688. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |